https://catalyze-capital.com/portfolio/2026-01-23T16:34:23+00:00https://catalyze-capital.com/team/2024-04-02T15:34:44+00:00https://catalyze-capital.com/2025-12-09T14:25:24+00:00https://catalyze-capital.com/about/2024-11-12T08:21:15+00:00https://catalyze-capital.com/focus/2024-04-02T15:19:38+00:00https://catalyze-capital.com/contact/2024-06-10T08:05:05+00:00https://catalyze-capital.com/privacy-policy/2024-03-20T11:40:16+00:00https://catalyze-capital.com/disclaimer/2024-03-20T11:49:14+00:00https://catalyze-capital.com/catalyze-capital-announces-first-closing/2024-04-03T08:15:45+00:00https://catalyze-capital.com/news/2025-12-09T14:24:25+00:00https://catalyze-capital.com/catalyze-capital-invests-in-gesynta-pharma-to-advance-endometriosis-treatment/2025-01-21T15:32:05+00:00https://catalyze-capital.com/catalyze-capital-invests-in-neuro-event-labs-to-accelerate-the-commercial-expansion-of-an-ai-powered-seizure-detection-device-for-epilepsy/2025-02-14T15:40:48+00:00https://catalyze-capital.com/neuro-event-labs-receives-fda-510k-clearance/2025-11-26T10:40:48+00:00https://catalyze-capital.com/catalyze-capital-invests-in-meltmarble-to-scale-precision-fermentation-fats/2025-12-09T14:22:10+00:00